CS Medica A/S (NGM: CSMED)
Sweden
· Delayed Price · Currency is SEK
6.05
-0.12 (-1.99%)
At close: Nov 15, 2024
CS Medica Balance Sheet
Financials in millions DKK. Fiscal year is October - September.
Millions DKK. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 |
Cash & Equivalents | 0.05 | -0.42 | 2.93 | 10 | 0.3 | - |
Cash & Short-Term Investments | 0.05 | -0.42 | 2.93 | 10 | 0.3 | - |
Cash Growth | - | - | -70.65% | 3267.00% | - | - |
Accounts Receivable | 2.34 | 2.45 | 6.49 | 1.64 | 0.05 | 0.11 |
Other Receivables | 0.26 | -0.09 | 0 | 1.46 | 0.07 | 0.05 |
Receivables | 2.6 | 2.37 | 6.49 | 3.1 | 0.12 | 0.16 |
Inventory | 1.46 | 2.71 | 1.35 | 1.23 | 1.12 | 0.46 |
Other Current Assets | 0.82 | - | 0 | - | - | 0 |
Total Current Assets | 4.93 | 4.66 | 10.78 | 14.33 | 1.98 | 1.18 |
Other Intangible Assets | 14.99 | 13.63 | 13.51 | 12.78 | 3.45 | 2.1 |
Long-Term Deferred Tax Assets | 10.07 | 7.46 | 3.51 | 0.23 | - | - |
Other Long-Term Assets | 4.18 | 0.11 | 0.11 | 0.08 | - | - |
Total Assets | 34.17 | 25.86 | 27.91 | 27.41 | 5.44 | 3.28 |
Accounts Payable | 9.22 | 5.11 | 1.19 | 0.5 | 0.49 | 0.13 |
Short-Term Debt | 1.09 | - | - | - | - | 0.4 |
Current Portion of Long-Term Debt | 2.08 | 0.19 | 0.45 | 0.4 | - | - |
Other Current Liabilities | 6.03 | 1.55 | 0.58 | 0.71 | 0.38 | 0.03 |
Total Current Liabilities | 18.42 | 6.85 | 2.22 | 1.62 | 0.87 | 0.57 |
Long-Term Debt | 9.13 | 8.59 | 0.59 | 1.31 | 3.23 | 3.52 |
Long-Term Deferred Tax Liabilities | - | - | - | - | 0.76 | 0.46 |
Other Long-Term Liabilities | 4.8 | - | 0.16 | 0.33 | 0.49 | 0.49 |
Total Liabilities | 32.35 | 15.44 | 2.98 | 3.26 | 5.35 | 5.04 |
Common Stock | 0.8 | 0.8 | 0.8 | 0.71 | 0.08 | 0.08 |
Retained Earnings | -8.24 | 1.69 | 16.69 | 16.29 | -2.68 | -3.47 |
Comprehensive Income & Other | 9.26 | 7.92 | 7.44 | 7.15 | 2.69 | 1.63 |
Shareholders' Equity | 1.82 | 10.41 | 24.93 | 24.15 | 0.09 | -1.76 |
Total Liabilities & Equity | 34.17 | 25.86 | 27.91 | 27.41 | 5.44 | 3.28 |
Total Debt | 12.3 | 8.78 | 1.04 | 1.72 | 3.23 | 3.92 |
Net Cash (Debt) | -12.25 | -9.19 | 1.89 | 8.28 | -2.93 | -3.92 |
Net Cash Growth | - | - | -77.16% | - | - | - |
Net Cash Per Share | -0.99 | -0.75 | 0.16 | 1.52 | - | - |
Filing Date Shares Outstanding | 12.32 | 12.32 | 12.32 | 10.9 | - | - |
Total Common Shares Outstanding | 12.32 | 12.32 | 12.32 | 10.9 | - | - |
Working Capital | -13.49 | -2.19 | 8.56 | 12.71 | 1.12 | 0.61 |
Book Value Per Share | 0.15 | 0.85 | 2.02 | 2.21 | - | - |
Tangible Book Value | -13.17 | -3.21 | 11.41 | 11.37 | -3.36 | -3.86 |
Tangible Book Value Per Share | -1.07 | -0.26 | 0.93 | 1.04 | - | - |
Order Backlog | - | 14.5 | - | - | - | - |
Source: S&P Capital IQ. Standard template. Financial Sources.